Angiosoma Overview

  • Status
  • Public

  • Employees
  • 1

Employees
  • Stock Symbol
  • GSTC

Stock Symbol
  • Investments
  • 1

Angiosoma General Information

Description

GlobeStar Therapeutics Corp is a clinical-stage Pharmaceutical Company introducing a patented formulation of previously approved drugs for the treatment of Multiple Sclerosis. The company is focused on developing innovative therapies for people with serious and life-threating rare disorders.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Pharmaceuticals
Other Industries
Other Pharmaceuticals and Biotechnology
Stock Exchange
PINX
Primary Office
  • 14001 Walden Road
  • Suite 600
  • Montgomery, TX 77356
  • United States
+1 (832) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Angiosoma Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$2.25M 643M 4.32M -$0.02

Angiosoma Financials Summary

In Thousands,
USD
TTM 31-Mar-2022 FY 2021 30-Sep-2021 FY 2020 30-Sep-2020 FY 2019 30-Sep-2019
EV 4,750 16,246 2,670 4,034
Revenue 0 0 0 1
EBITDA (9,647) (9,513) (302) (314)
Net Income (9,803) (9,802) (542) (675)
Total Assets 1 6 90 142
Total Debt 20 106 155 114
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Angiosoma Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Angiosoma‘s full profile, request access.

Request a free trial

Angiosoma Executive Team (2)

Name Title Board Seat Contact Info
Alex Blankenship President & Chief Executive Officer
Brooke Greenwald Chief Marketing Officer
To view Angiosoma’s complete executive team members history, request access »

Angiosoma Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Angiosoma Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Angiosoma‘s full profile, request access.

Request a free trial

Angiosoma Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000 00000 07-Jun-2016 0000000000 Energy Exploration
To view Angiosoma’s complete acquisitions history, request access »